Michael Arenberg - 06 Jan 2022 Form 4 Insider Report for DURECT CORP (DRRX)

Reporting relationship: Chief Financial Officer
Issuer ticker: DRRX
Reported as of: 06 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jan 2022, 16:49:05 UTC
Next SEC filing: 25 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Michael Arenberg

Key filing fact

Michael Arenberg filed Form 4 for DURECT CORP (DRRX) on 10 Jan 2022.

Key facts

This page summarizes Michael Arenberg's Form 4 filing for DURECT CORP (DRRX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jan 2022, 16:49.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DRRX transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +546,350
Change %
Price: $0.000000
Shares after: 546,350
Date: 06 Jan 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 546,350
Exercise price: $0.8710
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest and become exercisable in installments of one-sixteenth (1/16) of the total number of shares at the end of each three month period following the grant date, subject to the Reporting Person providing continuous service to the Issuer through the applicable vesting date.